CureVac Stock (NASDAQ:CVAC), Quotes and News Summary

Q: What sector and industry does CureVac (CVAC) operate in?

CureVac is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

CureVac Stock (NASDAQ: CVAC) stock price, news, charts, stock research, profile.

Open	$2.320
Close	$2.330
Volume / Avg.	837.605K / 796.540K
Day Range	2.280 - 2.420
52 Wk Range	2.215 - 12.360
Market Cap	$526.221M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	28
Short Interest	12.62%
Days to Cover	7.5

Recent News

COVID-19 Patent Dispute Sorted: Acuitas Therapeutics and CureVac Reach Settlement In Patent Battle

Acuitas Therapeutics settles lawsuit with CureVac over COVID-19 vaccine patents. Legal disputes unfold among biotech giants Pfizer, BioNTech, and CureVac, as GSK joins the fray, alleging patent infringement in mRNA technology.

Vandana Singh

Bill Gates Called For A 'Universal Flu Vaccine,' Now The CDC Director Says The Organization Is 'Activated' After Issuing Bird Flu Alert

Caleb Naysmith

CureVac, GSK Partner Release Data On Influenza Vaccine Study

CureVac reveals Phase 2 interim data for its seasonal influenza vaccine in collaboration with GSK. Results show broad antigen coverage with acceptable safety. Positive findings against influenza A strains prompt further optimization for influenza B strains.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

2.9

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

About

Sector

Healthcare

Industry

N/A

CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and ther...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy CureVac (CVAC) stock?

You can purchase shares of CureVac (NASDAQ: CVAC) through any online brokerage.

View our list of the best stock brokerages.

Who are CureVac's (CVAC) competitors?

There are no as such competitors for CureVac.

What is the target price for CureVac (CVAC) stock?

The latest price target for CureVac (NASDAQ: CVAC) was reported by Leerink Partners on Thursday, April 25, 2024. The analyst firm set a price target for 4.00 expecting CVAC to rise to within 12 months (a possible 70.21% upside). 4 analyst firms have reported ratings in the last year.

Current Stock Price for CureVac (CVAC)?

The stock price for CureVac (NASDAQ: CVAC) is $2.35 last updated April 26, 2024 at 9:29 AM EDT.

Does CureVac (CVAC) pay a dividend?

There are no upcoming dividends for CureVac.

When is CureVac (NASDAQ:CVAC) reporting earnings?

CureVac’s Q1 earnings are confirmed for Tuesday, May 28, 2024.

Is CureVac (CVAC) going to split?

There is no upcoming split for CureVac.

What sector and industry does CureVac (CVAC) operate in?

CureVac is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.